InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Friday, 04/23/2021 11:14:39 AM

Friday, April 23, 2021 11:14:39 AM

Post# of 233066
Right now everything rests on the theory that the critical patients need more than 2 doses. It is obviously the theory CytoDyn should embrace. But here is how drug development should proceed:

1. Develop a theory
2. Test the theory in a clinical trial
3. Look at the data when the trial completes
4. If it is good data, try for an EUA

Leronlimab's supporters are skipping steps when they complain that leronlimab hasn't been approved.

It is like you have announced leronlimab as MVP of the season before the season even began.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News